{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_mesalamine",
          "name": "Mesalamine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_tocilizumab",
          "name": "Tocilizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_loperamide",
          "name": "Loperamide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_probiotics",
          "name": "Probiotics"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tocilizumab",
          "type": "Drug",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_loperamide",
          "type": "Drug",
          "label": "Loperamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_probiotics",
          "type": "Drug",
          "label": "Probiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_IL10",
          "type": "Target",
          "label": "Interleukin 10",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_TNF-alpha",
          "type": "Target",
          "label": "Tumor Necrosis Factor-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_IFN-gamma",
          "type": "Target",
          "label": "Interferon gamma",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_anti-inflammatory",
          "type": "Pathway",
          "label": "Anti-inflammatory Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_immunomodulation",
          "type": "Pathway",
          "label": "Immunomodulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_GI_disorder",
          "type": "Disease",
          "label": "Gastrointestinal Epithelial Barrier Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_mesalamine",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知作用于抗炎介质"
        },
        {
          "source": "drug_infliximab",
          "target": "target_TNF-alpha",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "机制已广泛研究用于相关疾病"
        },
        {
          "source": "drug_adalimumab",
          "target": "target_TNF-alpha",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "与类似机制药物一致"
        },
        {
          "source": "drug_budesonide",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过调节抗炎反应的常识"
        },
        {
          "source": "drug_prednisone",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "具有广泛的免疫抑制作用"
        },
        {
          "source": "drug_ustekinumab",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响特定细胞因子通路"
        },
        {
          "source": "drug_tocilizumab",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "主要用于炎症相关性疾病"
        },
        {
          "source": "drug_methotrexate",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "作为抗炎药物的常见应用"
        },
        {
          "source": "drug_azathioprine",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于免疫调节的药物"
        },
        {
          "source": "drug_cyclosporine",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.58,
          "agent": "Proponent",
          "rationale": "用于抑制免疫反应"
        },
        {
          "source": "drug_loperamide",
          "target": "disease_GI_disorder",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "用于对抗腹泻相关的GI病理"
        },
        {
          "source": "drug_probiotics",
          "target": "disease_GI_disorder",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "通过改善肠道微生物群"
        },
        {
          "source": "target_IL10",
          "target": "pathway_anti-inflammatory",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抗炎通路的核心成分"
        },
        {
          "source": "target_TNF-alpha",
          "target": "pathway_anti-inflammatory",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "关键的炎症介质"
        },
        {
          "source": "target_IFN-gamma",
          "target": "pathway_immunomodulation",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫调节的必要成分"
        },
        {
          "source": "pathway_anti-inflammatory",
          "target": "disease_GI_disorder",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "通过抑制炎症来改善症状"
        },
        {
          "source": "pathway_immunomodulation",
          "target": "disease_GI_disorder",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响免疫反应的通路"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过干预不同靶点及通路对胃肠道上皮屏障疾病产生影响",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物能有效到达靶组织并发挥作用"
    ],
    "uncertainties": [
      "各药物的安全性和具体适应症需进一步验证"
    ],
    "next_focus_for_pi": [
      "需要评估不同剂量和组合药物的效果"
    ]
  }
}